pravastatin + paroxetine

Pravastatin + paroxetine is a combination of two pharmaceutical drugs, each with distinct mechanisms and indications. Pravastatin is an HMG-CoA reductase inhibitor (statin) used primarily to lower lipid levels and reduce the risk of cardiovascular events by inhibiting cholesterol biosynthesis in the liver, which leads to increased LDL receptor expression and enhanced clearance of LDL cholesterol[8]. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that increases synaptic serotonin levels by inhibiting its presynaptic reuptake, thereby treating depression, anxiety disorders, obsessive-compulsive disorder, posttraumatic stress disorder, and vasomotor symptoms associated with menopause[5][6]. When administered together, these drugs have been shown in studies to synergistically increase blood glucose levels—particularly in patients with diabetes—though the mechanism for this interaction remains unclear[1][2][3][4].